Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Awards Granted (Details)

v3.22.2.2
Schedule of Stock Awards Granted (Details)
 3 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of Shares, Outstanding, Beginning balance | shares 1,911,459
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 4.63
Weighted Average Remaining Contractual Term (Years), Outstanding, Beginning balance 4 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding, Beginning balance | $
Number of Shares, Granted | shares 8,242
Weighted Average Exercise Price, Granted | $ / shares $ 5.49
Number of Shares, Exercised | shares (24,000)
Weighted Average Exercise Price, Exercised | $ / shares $ 2.18
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Number of Shares, Outstanding, Ending balance | shares 1,895,701
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares $ 4.66
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance 4 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding, Ending balance | $ $ 357,916
Number of Shares, Exercisable, Ending balance | shares 315,386
Weighted Average Exercise Price, Exercisable, Ending balance | $ / shares $ 2.59
Weighted Average Remaining Contractual Term (Years), Exercisable, Ending balance 3 years 6 months
Aggregate Intrinsic Value, Exercisable, Ending balance | $ $ 177,868